Scilex Holding Co(SCLX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Scilex Holding Co (SCLX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SCLX at 9.1/100 on a 32-signal composite quality model, placing it at rank #2,923 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (0.2) and profitability (2.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 4.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Scilex Holding Co reports quarterly revenue of $7.6M, net income of $-115.0M. Top institutional holders of SCLX by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock, VANGUARD FIDUCIARY, based on the most recent SEC filings. SCLX trades on the Nasdaq exchange and files with the SEC under CIK 1820190. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SCLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Scilex Holding Co directly from SEC EDGAR.

AI Quality Score

9.1/100

AI Rank

#2,923

Revenue

$7.6M

Net Income

$-115.0M

SCLX key financials by period

Scilex Holding Co reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$30.3M$-374.1M
FY 202410-K$56.6M$-72.8M-147.4%
FY 202310-K$46.7M$-114.3M
FY 202210-K$38.0M$-23.4M-133.1%
FY 202110-K$31.3M$-88.4M-114.4%
FY 202010-K$23.6M$-47.5M-149.7%

Institutions holding SCLX

Institutional investors reporting a position in Scilex Holding Co on SEC Form 13F.
InstitutionSharesValueReported
VANGUARD CAPITAL MANAGEMENT301,292$2.4M2026-06-30
BlackRock109,417$853.5K2026-06-30
VANGUARD FIDUCIARY45,822$357.4K2026-06-30
JACOBS LEVY EQUITY MANAGEMENT41,163$321.1K2026-06-30
STATE STREET35,376$275.9K2026-06-30
UBS Group AG33,376$260.3K2026-06-30
RENAISSANCE TECHNOLOGIES33,064$257.9K2026-06-30
CITADEL ADVISORS27,497$214.5K2026-06-30
PRICE T ROWE ASSOCIATES20,920$164.0K2026-06-30
Ashton Thomas Private Wealth18,482$144.2K2026-06-30
SCLX

Scilex Holding Co

SCLX
NasdaqSmall CapHealthcare

13F Pro Quality Score

9.1/100

Rank #2,923 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

3.6/100

Profitability

2.0/100

Balance Sheet

0.2/100

Earnings Quality

46.5/100

Free Cash Flow

9.0/100

Institutional Flow

15.4/100

Revenue Scale

5.6/100

Dilution Risk

4.6/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$7.64M

Net Income

Q2 2026
EDGAR

$-114.99M

EPS (Diluted)

Q2 2026
EDGAR

$-16.65

Top Institutional Holders

as of Q2 2026
$5.48M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…